Verdict
🟠 Highly suspicious. Multiple internal inconsistencies and biologically implausible specifications in the Materials and Methods section raise serious concerns about the reliability and authenticity of the reported experiments. Image-based and statistical forensic analyses could not be completed.
Key findings
- Implausible cell seeding density in Transwell assay. The methods state that 1×10^6 (1,000,000) cells were seeded into the upper chamber. Standard 24-well Transwell inserts (8 μm pore, <0.5 cm² membrane area) are routinely loaded with 2×10^4 to 5×10^4 cells. A 1×10^6 cell load would produce immediate overcrowding, nutrient depletion, and massive cell death or physical drop-through, invalidating the assay.
- Incorrect reagent attribution for β-actin antibody. The antibody is assigned to Abcam (Cambridge, MA, USA) with catalog number AP0060. Abcam catalog numbers use the 'ab' prefix (e.g., ab8226 for β-actin). AP0060 is not an Abcam catalog number and is associated with other suppliers, indicating a misattribution likely arising from careless copying.
- Contradictory proliferation/viability assays. The methods describe both the MTS assay and the Cell Counting Kit-8 (CCK-8) assay for parallel proliferation experiments without explaining the switch. Laboratories typically standardize on a single assay; this inconsistency suggests the methods section may be compiled from heterogeneous sources.
- Inability to assess image integrity. Western blot bands and bar-graph figures could not be examined for pixel-level duplication, splicing, or reuse. No underlying numerical tables were available for last-digit or other statistical forensic tests.
- Direct textual statement from Materials and Methods: "1 × 10^6" cells seeded in Transwell invasion assay (pp. 2–3).
- Antibody list attributes all primary antibodies (Nrf2, HO-1, NQO-1, MMP-2/9, E-cadherin, N-cadherin, β-actin) to Abcam, with β-actin listed as (AP0060).
- Methods state: "The MTS assay was performed… Proliferation assays were performed using the cell counting Kit-8 (CCK-8) kit."
- DOI: 10.1177/15593258211033114; Journal: *Dose-Response*, 2021.
- All findings above are derived solely from the textual content of the article; no figure-level or data-level forensic analyses were possible with the materials provided.
- The 1×10^6 cell figure may reflect a typographical error (off by 1–2 orders of magnitude), but the absence of any correction or clarification, combined with the antibody misattribution, undermines confidence in the methods as written.
- A formal editorial or institutional investigation is warranted, particularly if original Transwell images, cell-counting records, and antibody purchase invoices can be obtained.
- This automated assessment is intended for academic discussion and does not constitute a determination of misconduct.